循环黏附分子与亚临床间质性肺病:MESA研究
在MESA队列45-84岁社区成人中,分析了sICAM-1、sVCAM-1和P-selectin与亚临床ILD的关联。结果提示这些黏附分子水平升高与CT高衰减区、间质性肺异常、肺功能下降及ILD住院和死亡风险增加独立相关。
要点
- sICAM-1、sVCAM-1和P-selectin升高与CT高衰减区增加相关
- sICAM-1与间质性肺异常患病率及FVC下降相关
- sVCAM-1和P-selectin升高与ILD死亡风险增加相关
核心结论
- 循环sICAM-1、sVCAM-1和P-selectin水平升高与社区成人亚临床ILD的CT和肺功能指标独立相关,并与裁定ILD事件发生率增加相关。
研究设计与样本
- 多民族动脉粥样硬化研究(MESA)于2000-2002年在美国六个社区纳入45-84岁男性和女性。
- 通过心脏CT定义高衰减区,全肺CT评估间质性肺异常,部分个体行肺量计检查,并裁定ILD住院和死亡。
主要发现
- sICAM-1、sVCAM-1和P-selectin每升高一个单位,高衰减区分别增加2.94%(95%CI 1.80-4.07%)、1.24%(95%CI 0.14-2.35%)和1.58%(95%CI 0.92-2.23%)。
- sICAM-1、sVCAM-1和P-selectin与ILD住院率增加相关,HR分别为1.36(95%CI 1.03-1.80)、1.40(95%CI 1.07-1.85)和2.03(95%CI 1.16-3.5)。
- sICAM-1与间质性肺异常患病率增加相关(OR 1.39,95%CI 1.13-1.71)。
- sICAM-1和P-selectin与FVC降低相关,分别降低44 mL(95%CI 12-76 mL)和29 mL(95%CI 8-49 mL)。
- sVCAM-1和P-selectin与ILD死亡风险增加相关,HR分别为2.15(95%CI 1.26-3.64)和3.61(95%CI 1.54-8.46)。
临床怎么用
- 在社区成人中,检测循环sICAM-1、sVCAM-1和P-selectin可能有助于识别亚临床ILD高风险个体。
- 黏附分子升高提示需关注CT高衰减区、间质性肺异常及肺功能下降,并警惕ILD住院和死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adhesion molecules may contribute to the development of interstitial lung disease (ILD) and have been proposed as prognostic biomarkers in idiopathic pulmonary fibrosis. Our objective was to determine whether the circulating adhesion molecules soluble intracellular adhesion molecule (sICAM)-1, soluble vascular cell adhesion molecule (sVCAM)-1 and P-selectin are associated with subclinical ILD in community-dwelling adults.The Multi-Ethnic Study of Atherosclerosis enrolled males and females aged 45-84 years from six communities in the United States in 2000-2002. High attenuation areas were defined as the percentage of imaged lung volume with attenuation -600--250 HU on cardiac computed tomography (CT). Interstitial lung abnormalities were visually assessed on full-lung CT. Spirometry was performed on a subset of individuals. ILD hospitalisations and deaths were adjudicated.In fully adjusted analyses, higher levels of sICAM-1, sVCAM-1 and P-selectin were associated with greater high attenuation areas (2.94%, 95% CI 1.80-4.07%; 1.24%, 95% CI 0.14-2.35%; and 1.58%, 95% CI 0.92-2.23%, respectively), and greater rate of ILD hospitalisations (HR 1.36, 95% CI 1.03-1.80; 1.40, 95% CI 1.07-1.85; and 2.03, 95% CI 1.16-3.5, respectively). sICAM-1 was associated with greater prevalence of interstitial lung abnormalities (OR 1.39, 95% CI 1.13-1.71). sICAM-1 and P-selectin were associated with lower forced vital capacity (44 mL, 95% CI 12-76 mL and 29 mL, 95% CI 8-49 mL, respectively). sVCAM-1 and P-selectin were associated with increased risk of ILD death (HR 2.15, 95% CI 1.26-3.64 and 3.61, 95% CI 1.54-8.46, respectively).Higher levels of circulating sICAM-1, sVCAM-1 and P-selectin are independently associated with CT and spirometric measures of subclinical ILD, and increased rate of adjudicated ILD events among community-dwelling adults.
引用
- McGroder CF, Aaron CP, Bielinski SJ, et al. Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Eur Respir J. 2019. PMID: 31371443. doi:10.1183/13993003.00295-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。